Remnant living cells that escape cell loss in late-stage tumors exhibit cancer stem cell-like characteristics

Cell Death and Disease

Volumn 3, Issue 10, 2012, Pages

  Chen, Y L ^a   Wang, S Y ^a   Liu, R S ^a,b   Wang, H E ^a   Chen, J C ^a   Chiou, S H ^a,b   Chang, C A ^a   Lin, L T ^a   Tan, D T W ^a   Lee, Y J ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Cancer stem cells; Cell loss factor; PiggyBac transposon system; Remnant living cells; Reporter gene imaging; Syngeneic tumor model

Indexed keywords

CD133 ANTIGEN; FIALURIDINE; GANCICLOVIR; OCTAMER TRANSCRIPTION FACTOR 4; RED FLUORESCENT PROTEIN; THYMIDINE KINASE; TRANSCRIPTION FACTOR SOX;

ARTICLE; CANCER CELL CULTURE; CANCER SCINTISCANNING; CANCER STEM CELL; CELL ISOLATION; CELL LOSS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EX VIVO STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; PIGGYBAC TRANSPOSON; PRIORITY JOURNAL; REPORTER GENE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TRANSPOSON; TUMOR MODEL;

ANIMALS; ANTIGENS, CD; CELL LINE, TUMOR; FEMALE; GLYCOPROTEINS; HEK293 CELLS; HUMANS; MICE; MICE, INBRED BALB C; NEOPLASM, RESIDUAL; NEOPLASMS; NEOPLASTIC STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3; PEPTIDES; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; SOXB1 TRANSCRIPTION FACTORS; TRANSFECTION; TRANSPLANTATION, HOMOLOGOUS;

ANIMALIA; HUMAN HERPESVIRUS 1;

EID: 84870514402     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2012.136     Document Type: Article

References (38)

1. Steel GG. Cell loss as a factor in the growth rate of human tumours. Eur J Cancer 1967; 3: 381-387.
2. Cooper EH, Bedford AJ, Kenny TE. Cell death in normal and malignant tissues. Adv Cancer Res 1975; 21: 59-120.
3. Serganova I, Mayer-Kukuck P, Huang R, Blasberg R. Molecular imaging: reporter gene imaging. Handb Exp Pharmacol 2008; 185/2: 167-223.
4. Acton PD, Zhou R. Imaging reporter genes for cell tracking with PET and SPECT. Q J Nucl Med Mol Imaging 2005; 49: 349-360.
5. Kircher MF, Gambhir SS, Grimm J. Noninvasive cell-tracking methods. Nat Rev Clin Oncol 2011; 8: 677-688.
6. Diehn M, Clarke MF. Cancer stem cells and radiotherapy: new insights into tumor radioresistance. J Natl Cancer Inst 2006; 98: 1755-1757.
7. Wang HE, Yu HM, Liu RS, Lin M, Gelovani JG, Hwang JJ et al. Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer. J Nucl Med 2006; 47: 1161-1171.
8. Haubner R, Avril N, Hantzopoulos PA, Gansbacher B, Schwaiger M. In vivo imaging of herpes simplex virus type 1 thymidine kinase gene expression: early kinetics of radiolabelled FIAU. Eur J Nucl Med 2000; 27: 283-291.
9. Love Z, Wang F, Dennis J, Awadallah A, Salem N, Lin Y et al. Imaging of mesenchymal stem cell transplant by bioluminescence and PET. J Nucl Med 2007; 48: 2011-2020.
10. Ray P. The pivotal role of multimodality reporter sensors in drug discovery: from cell based assays to real time molecular imaging. Curr Pharm Biotechnol 2011; 12: 539-546.
11. De A, Lewis XZ, Gambhir SS. Noninvasive imaging of lentiviral-mediated reporter gene expression in living mice. Mol Ther 2003; 7: 681-691.
12. Lam AP, Dean DA. Progress and prospects: nuclear import of nonviral vectors. Gene Ther 2010; 17: 439-447.
13. Claeys Bouuaert C, Chalmers RM. Gene therapy vectors: the prospects and potentials of the cut-and-paste transposons. Genetica 2010; 138: 473-484.
14. Kim A, Pyykko I. Size matters: versatile use of PiggyBac transposons as a genetic manipulation tool. Mol Cell Biochem 2011; 354: 301-309.
15. Kang Y, Zhang X, Jiang W, Wu C, Chen C, Zheng Y et al. Tumor-directed gene therapy in mice using a composite nonviral gene delivery system consisting of the piggyBac transposon and polyethylenimine. BMC cancer 2009; 9: 126.
16. Nakazawa Y, Huye LE, Salsman VS, Leen AM, Ahmed N, Rollins L et al. PiggyBacmediated cancer immunotherapy using EBV-specific cytotoxic T-cells expressing HER2-specific chimeric antigen receptor. Mol Ther 2011; 19: 2133-2143.
17. VandenDriessche T, Ivics Z, Izsvak Z, ChuahMK. Emerging potential of transposons for gene therapy and generation of induced pluripotent stem cells. Blood 2009; 114: 1461-1468.
18. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001; 414: 105-111.
19. Zhang M, Rosen JM. Stem cells in the etiology and treatment of cancer. Curr Opin Genet Dev 2006; 16: 60-64.
20. Caruso M, Panis Y, Gagandeep S, Houssin D, Salzmann JL, Klatzmann D. Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc Natl Acad Sci USA 1993; 90: 7024-7028.
21. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008; 8: 755-768.
22. Chiodi I, Belgiovine C, Dona F, Scovassi AI, Mondello C. Drug treatment of cancer cell lines: a way to select for cancer stem cells? Cancers 2011; 3: 1111-1128.
23. Beier D, Hau P, Proescholdt M, Wischhusen J, Oefner PJ, Aigner L et al. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 2007; 67: 4010-4015.
24. Broadley KW, Hunn MK, Farrand KJ, Price KM, Grasso C, Miller RJ et al. Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme. Stem Cells 2011; 29: 452-461.
25. Schatton T, Frank MH. The in vitro spheroid melanoma cell culture assay: cues on tumor initiation? J Invest Dermatol 2010; 130: 1769-1771.
26. Vlashi E, Kim K, Lagadec C, Donna LD, McDonald JT, Eghbali M et al. In vivo imaging, tracking, and targeting of cancer stem cells. J Natl Cancer Inst 2009; 101: 350-359.
27. Hermann PC, Bhaskar S, Cioffi M, Heeschen C. Cancer stem cells in solid tumors. Sem Cancer Biol 2010; 20: 77-84.
28. Hart LS, El-Deiry WS. Invincible, but not invisible: imaging approaches toward in vivo detection of cancer stem cells. J Clin Oncol 2008; 26: 2901-2910.
29. Borovski T, De Sousa EMF, Vermeulen L, Medema JP. Cancer stem cell niche: the place to be. Cancer Res 2011; 71: 634-639.
30. Tao K, Fang M, Alroy J, Sahagian GG. Imagable 4T1 model for the study of late stage breast cancer. BMC cancer 2008; 8: 228.
31. Frindel E, Malaise EP, Alpen E, Tubiana M. Kinetics of cell proliferation of an experimental tumor. Cancer Res 1967; 27: 1122-1131.
32. Huszthy PC, Giroglou T, Tsinkalovsky O, Euskirchen P, Skaftnesmo KO, Bjerkvig R et al. Remission of invasive, cancer stem-like glioblastoma xenografts using lentiviral vectormediated suicide gene therapy. PLoS One 2009; 4: e6314.
33. Tsai CH, Chiu SJ, Liu CC, Sheu TJ, Hsieh CH, Keng PC et al. Regulated expression of cofilin and the consequent regulation of p27(kip1) are essential for G(1) phase progression. Cell Cycle 2009; 8: 2365-2374.
34. Kang Y, Zhang XY, Jiang W, Wu CQ, Chen CM, Gu JR et al. The piggyBac transposon is an integrating non-viral gene transfer vector that enhances the efficiency of GDEPT. Cell Biol Int 2009; 33: 509-515.
35. Dierlamm J, Wlodarska I, Michaux L, La Starza R, Zeller W, Mecucci C et al. Successful use of the same slide for consecutive fluorescence in situ hybridization experiments. Genes Chromosomes Cancer 1996; 16: 261-264.
36. Yang FY, Wang HE, Lin GL, Teng MC, Lin HH, Wong TT et al. Micro-SPECT/CT-based pharmacokinetic analysis of 99mTc- diethylenetriaminepentaacetic acid in rats with bloodbrain barrier disruption induced by focused ultrasound. J Nucl Med 2011; 52: 478-484.
37. Loening AM, Gambhir SS. AMIDE: a free software tool for multimodality medical image analysis. Mol Imaging 2003; 2: 131-137.
38. Chew JL, Loh YH, Zhang W, Chen X, Tam WL, Yeap LS et al. Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells. Mol Cell Biol 2005; 25: 6031-6046.